Cell MedX Corp. Annual Return On Equity in % from 2019 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cell MedX Corp. quarterly/annual Return On Equity history and growth rate from 2019 to 2021.
  • Cell MedX Corp. Return On Equity for the quarter ending May 31, 2022 was 39.2 %, a 28.5% decline year-over-year.
  • Cell MedX Corp. annual Return On Equity for 2021 was 42 %, a 95.9% decline from 2020.
  • Cell MedX Corp. annual Return On Equity for 2020 was 1.03K %, a 1348% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 42 -985 -95.9% Jun 1, 2021 May 31, 2022
2020 1.03K +956 +1348% Jun 1, 2020 May 31, 2021
2019 70.9 Jun 1, 2019 May 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.